News
By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...
For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...
Proposed Indian bills could oust elected officials jailed over 30 days, sparking opposition uproar. Critics fear misuse ...
Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...
2d
GlobalData on MSNAdvancing rare disease trials by overcoming patient recruitment challenges
The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.
The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...
Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...
Two horses have been humanely euthanised after sustaining fatal injuries in unrelated incidents at the first Scone Palace ...
A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...
Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results